Blanket Purchase Agreement 36F79721D0239-36E79721A0022

Travere Therapeutics, Inc. holds a Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs (VA) National Acquisition Center valued at $25,000,000. This BPA is specifically for the procurement of Travere's pharmaceutical products Thiola and Cholbam, which are used to treat rare kidney and liver conditions, respectively. Travere also holds a Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB), valued up to $14,970,593.10, which serves as the foundation for additional delivery orders placed by VA medical facilities to acquire Travere's full range of specialty drugs. The combination of the BPA and FSS contract demonstrates Travere's significant role as a supplier of rare disease medications to the federal healthcare system, particularly in supporting the VA's mission to provide care to over 9 million enrolled veterans. Delivery orders under these IDVs have ranged from approximately $11,000 to $236,500, with performance periods generally spanning a few days to one year. The VA has been the predominant funding agency for these contracts, which do not utilize any specific set-aside categories.